The BA.4.6 variant now accounts for >12% of US cases, steadily rising. Its Arg346 mutation, shared w/ many of the new variants, makes it more immune evasive than BA.5, resistant to Evusheld prophylaxis and potential of reinfections after BA.5 https://t.co/bWu7dP3OOp @yunlong_cao pic.twitter.com/IMbk58HWqs
— Eric Topol (@EricTopol) September 27, 2022
The more we learn more about 'long COVID' the more concerning the situation seems to be.
— AMA President (@amapresident) September 27, 2022
Nobody can see the future with such a newly-recognized virus, but it looks like we need to prepare for a major impact.💣💥#LongCovid #CovidIsNotOver
https://t.co/0hDyyYuaSE pic.twitter.com/2GSnmTWxXv
(1/n) Nature: Lingering cardiac involvement in previously well people after mild COVID-19: persistent subclinical cardiovascular inflammation seems to predispose people to a poor prognosis and the development of heart failure. https://t.co/2d96SqD0gr
— Roland Baker (@RolandBakerIII) September 27, 2022
Time between reinfections seem to be condensing https://t.co/RM3c5lyFAv
— Alex Meshkin, GED (@alexmeshkin) September 26, 2022
Finding patterns in the chaos of #LongCovid...
— Diana Zicklin Berrent (@dianaberrent) September 26, 2022
We surveyed 5,652 people with Long Covid (most never hospitalized with acute disease) and allowed them to chart their symptoms over time.
---> Onset of symptom clusters happened in a predictable fashion.https://t.co/LhNSwI85BX
No comments:
Post a Comment